{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:41:11Z","timestamp":1790314871650,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s42000-024-00608-0","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:02:29Z","timestamp":1728532949000},"page":"601-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The molecular genetics of adrenal cushing"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3195-1629","authenticated-orcid":false,"given":"Patricia","family":"Vaduva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"608_CR1","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/ERC-17-0361","volume":"25","author":"F Bonnet-Serrano","year":"2018","unstructured":"Bonnet-Serrano F, Bertherat J (2018) Genetics of tumors of the adrenal cortex. Endocrine-related Cancer 25:R131\u2013R152. https:\/\/doi.org\/10.1530\/ERC-17-0361","journal-title":"Endocrine-related Cancer"},{"key":"608_CR2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM et al (2008) The diagnosis of Cushing\u2019s syndrome: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR3","doi-asserted-by":"publisher","first-page":"e1362","DOI":"10.1210\/clinem\/dgaa752","volume":"106","author":"CH Ahn","year":"2021","unstructured":"Ahn CH, Kim JH, Park MY, Kim SW (2021) Epidemiology and comorbidity of adrenal cushing syndrome: a Nationwide Cohort Study. J Clin Endocrinol Metab 106:e1362\u2013e1372. https:\/\/doi.org\/10.1210\/clinem\/dgaa752","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR4","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J et al (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the study of adrenal tumors. Eur J Endocrinol 189:G1\u201342. https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"key":"608_CR5","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1210\/jc.2011-1565","volume":"96","author":"W Arlt","year":"2011","unstructured":"Arlt W, Biehl M, Taylor AE, Hahner S, Lib\u00e9 R, Hughes BA et al (2011) Urine steroid Metabolomics as a Biomarker Tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metabolism 96:3775\u20133784. https:\/\/doi.org\/10.1210\/jc.2011-1565","journal-title":"J Clin Endocrinol Metabolism"},{"key":"608_CR6","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing\u2019s syndrome. Lancet 367:1605\u20131617. https:\/\/doi.org\/10.1016\/S0140-6736(06)68699-6","journal-title":"Lancet"},{"key":"608_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.beem.2008.10.011","volume":"23","author":"A Lacroix","year":"2009","unstructured":"Lacroix A (2009) ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:245\u2013259. https:\/\/doi.org\/10.1016\/j.beem.2008.10.011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"608_CR8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","volume":"322","author":"JP Luton","year":"1990","unstructured":"Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322:1195\u20131201. https:\/\/doi.org\/10.1056\/NEJM199004263221705","journal-title":"N Engl J Med"},{"key":"608_CR9","doi-asserted-by":"publisher","first-page":"dgz136","DOI":"10.1210\/clinem\/dgz136","volume":"105","author":"G Rubinstein","year":"2020","unstructured":"Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S et al (2020) Time to diagnosis in Cushing\u2019s syndrome: a Meta-analysis based on 5367 patients. J Clin Endocrinol Metab 105:dgz136. https:\/\/doi.org\/10.1210\/clinem\/dgz136","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR10","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","volume":"189","author":"ICM Pelsma","year":"2023","unstructured":"Pelsma ICM, Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A et al (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. Eur J Endocrinol 189:S88\u2013101. https:\/\/doi.org\/10.1093\/ejendo\/lvad134","journal-title":"Eur J Endocrinol"},{"key":"608_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2008-2333","volume":"94","author":"J Bertherat","year":"2009","unstructured":"Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L et al (2009) Mutations in Regulatory Subunit Type 1A of cyclic adenosine 5\u2032-Monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metabolism 94:2085\u20132091. https:\/\/doi.org\/10.1210\/jc.2008-2333","journal-title":"J Clin Endocrinol Metabolism"},{"key":"608_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein F, Fassnacht M, Assi\u00e9 G, Calebiro D, Stratakis CA, Osswald A et al (2014) Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N Engl J Med 370:1019\u20131028. https:\/\/doi.org\/10.1056\/NEJMoa1310359","journal-title":"N Engl J Med"},{"key":"608_CR13","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1210\/jc.2008-0631","volume":"93","author":"S Gaujoux","year":"2008","unstructured":"Gaujoux S, Tissier F, Groussin L, Lib\u00e9 R, Ragazzon B, Launay P et al (2008) Wnt\/beta-catenin and 3\u2019,5\u2019-cyclic adenosine 5\u2019-monophosphate\/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J Clin Endocrinol Metab 93:4135\u20134140. https:\/\/doi.org\/10.1210\/jc.2008-0631","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR14","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","volume":"65","author":"F Tissier","year":"2005","unstructured":"Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagner\u00e9 A-M et al (2005) Mutations of \u03b2-Catenin in Adrenocortical tumors: activation of the wnt signaling pathway is a frequent event in both Benign and Malignant Adrenocortical tumors. Cancer Res 65:7622\u20137627. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0593","journal-title":"Cancer Res"},{"key":"608_CR15","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358\u20135362","journal-title":"Cancer Res"},{"key":"608_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747\u2013752. https:\/\/doi.org\/10.7326\/0003-4819-71-4-747","journal-title":"Ann Intern Med"},{"key":"608_CR17","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233\u20131238. https:\/\/doi.org\/10.1126\/science.1978757","journal-title":"Science"},{"key":"608_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/jnci\/86.22.1707","volume":"86","author":"J Wagner","year":"1994","unstructured":"Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D (1994) High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 86:1707\u20131710. https:\/\/doi.org\/10.1093\/jnci\/86.22.1707","journal-title":"J Natl Cancer Inst"},{"key":"608_CR19","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1038\/ncomms7302","volume":"6","author":"EM Pinto","year":"2015","unstructured":"Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S et al (2015) Genomic landscape of paediatric adrenocortical tumours. Nat Commun 6:6302. https:\/\/doi.org\/10.1038\/ncomms7302","journal-title":"Nat Commun"},{"key":"608_CR20","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1210\/jc.2012-2198","volume":"98","author":"VM Raymond","year":"2013","unstructured":"Raymond VM, Else T, Everett JN, Long JM, Gruber SB, Hammer GD (2013) Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98:E119\u2013125. https:\/\/doi.org\/10.1210\/jc.2012-2198","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR21","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1210\/jc.2011-1982","volume":"97","author":"LJM Herrmann","year":"2012","unstructured":"Herrmann LJM, Heinze B, Fassnacht M, Willenberg HS, Quinkler M, Reisch N et al (2012) TP53 germline mutations in adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab 97:E476\u2013485. https:\/\/doi.org\/10.1210\/jc.2011-1982","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J et al (2016) TP53 variations in human cancers: New lessons from the IARC TP53 database and Genomics Data. Hum Mutat 37:865\u2013876. https:\/\/doi.org\/10.1002\/humu.23035","journal-title":"Hum Mutat"},{"key":"608_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1590\/s0004-27302004000500009","volume":"48","author":"EM Pinto","year":"2004","unstructured":"Pinto EM, Billerbeck AEC, Villares MCBF, Domenice S, Mendon\u00e7a BB, Latronico AC (2004) Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq Bras Endocrinol Metabol 48:647\u2013650. https:\/\/doi.org\/10.1590\/s0004-27302004000500009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"608_CR24","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/cncr.30703","volume":"123","author":"MJ Mastellaro","year":"2017","unstructured":"Mastellaro MJ, Seidinger AL, Kang G, Abrah\u00e3o R, Miranda ECM, Pounds SB et al (2017) Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: insights from the study of 55 families of children with adrenocortical tumors. Cancer 123:3150\u20133158. https:\/\/doi.org\/10.1002\/cncr.30703","journal-title":"Cancer"},{"key":"608_CR25","doi-asserted-by":"publisher","first-page":"e18015","DOI":"10.1371\/journal.pone.0018015","volume":"6","author":"G Custodio","year":"2011","unstructured":"Custodio G, Taques GR, Figueiredo BC, Gugelmin ES, Oliveira Figueiredo MM, Watanabe F et al (2011) Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. PLoS ONE 6:e18015. https:\/\/doi.org\/10.1371\/journal.pone.0018015","journal-title":"PLoS ONE"},{"key":"608_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/jmedgenet-2017-104976","volume":"55","author":"M Renaux-Petel","year":"2018","unstructured":"Renaux-Petel M, Charbonnier F, Th\u00e9ry J-C, Fermey P, Lienard G, Bou J et al (2018) Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome. J Med Genet 55:173\u2013180. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104976","journal-title":"J Med Genet"},{"key":"608_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00279003","volume":"81","author":"I Henry","year":"1989","unstructured":"Henry I, Jeanpierre M, Couillin P, Barichard F, Serre JL, Journel H et al (1989) Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma. Hum Genet 81:273\u2013277. https:\/\/doi.org\/10.1007\/BF00279003","journal-title":"Hum Genet"},{"key":"608_CR28","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1210\/jcem.85.5.6589","volume":"85","author":"F Wilkin","year":"2000","unstructured":"Wilkin F, Gagn\u00e9 N, Paquette J, Oligny LL, Deal C (2000) Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. J Clin Endocrinol Metab 85:2048\u20132056. https:\/\/doi.org\/10.1210\/jcem.85.5.6589","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR29","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","volume":"31","author":"VM Raymond","year":"2013","unstructured":"Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB et al (2013) Adrenocortical carcinoma is a lynch syndrome-associated cancer. J Clin Oncol 31:3012\u20133018. https:\/\/doi.org\/10.1200\/JCO.2012.48.0988","journal-title":"J Clin Oncol"},{"key":"608_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","volume":"392","author":"J Waldmann","year":"2007","unstructured":"Waldmann J, Bartsch DK, Kann PH, Fendrich V, Rothmund M, Langer P (2007) Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 392:437\u2013443. https:\/\/doi.org\/10.1007\/s00423-006-0124-7","journal-title":"Langenbecks Arch Surg"},{"key":"608_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/EJE-17-0358","volume":"177","author":"T Else","year":"2017","unstructured":"Else T, Lerario AM, Everett J, Haymon L, Wham D, Mullane M et al (2017) Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. Eur J Endocrinol 177:439\u2013444. https:\/\/doi.org\/10.1530\/EJE-17-0358","journal-title":"Eur J Endocrinol"},{"key":"608_CR32","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","volume":"16","author":"S Gaujoux","year":"2010","unstructured":"Gaujoux S, Pinson S, Gimenez-Roqueplo A-P, Amar L, Ragazzon B, Launay P et al (2010) Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin Cancer Res 16:5133\u20135141. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1497","journal-title":"Clin Cancer Res"},{"key":"608_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-005-0376-z","volume":"75","author":"AS Wagner","year":"2005","unstructured":"Wagner AS, Fleitz JM, Kleinschmidt-Demasters BK (2005) Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature. J Neurooncol 75:127\u2013133. https:\/\/doi.org\/10.1007\/s11060-005-0376-z","journal-title":"J Neurooncol"},{"key":"608_CR34","doi-asserted-by":"publisher","first-page":"e4756","DOI":"10.1097\/MD.0000000000004756","volume":"95","author":"N El Ghorayeb","year":"2016","unstructured":"El Ghorayeb N, Grunenwald S, Nolet S, Primeau V, C\u00f4t\u00e9 S, Maugard CM et al (2016) First case report of an adrenocortical carcinoma caused by a BRCA2 mutation. Med (Baltim) 95:e4756. https:\/\/doi.org\/10.1097\/MD.0000000000004756","journal-title":"Med (Baltim)"},{"key":"608_CR35","doi-asserted-by":"publisher","unstructured":"Else T, Rodriguez-Galindo C (2016) 5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids! Horm Cancer;7:36\u20139. https:\/\/doi.org\/10.1007\/s12672-015-0244-z","DOI":"10.1007\/s12672-015-0244-z"},{"key":"608_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/j.seminoncol.2016.08.007","volume":"43","author":"EJ Petr","year":"2016","unstructured":"Petr EJ, Else T (2016) Genetic predisposition to endocrine tumors: diagnosis, surveillance and challenges in care. Semin Oncol 43:582\u2013590. https:\/\/doi.org\/10.1053\/j.seminoncol.2016.08.007","journal-title":"Semin Oncol"},{"key":"608_CR37","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/jcem.78.3.8126158","volume":"78","author":"M Reincke","year":"1994","unstructured":"Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM et al (1994) p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 78:790\u2013794. https:\/\/doi.org\/10.1210\/jcem.78.3.8126158","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ijc.2910540310","volume":"54","author":"H Ohgaki","year":"1993","unstructured":"Ohgaki H, Kleihues P, Heitz PU (1993) p53 mutations in sporadic adrenocortical tumors. Int J Cancer 54:408\u2013410. https:\/\/doi.org\/10.1002\/ijc.2910540310","journal-title":"Int J Cancer"},{"key":"608_CR39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1210\/jcem.78.6.7911125","volume":"78","author":"C Gicquel","year":"1994","unstructured":"Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton JP, Girard F et al (1994) Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 78:1444\u20131453. https:\/\/doi.org\/10.1210\/jcem.78.6.7911125","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR40","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1210\/jcem.82.8.4170","volume":"82","author":"C Gicquel","year":"1997","unstructured":"Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M et al (1997) Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab 82:2559\u20132565. https:\/\/doi.org\/10.1210\/jcem.82.8.4170","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assi\u00e9","year":"2014","unstructured":"Assi\u00e9 G, Letouz\u00e9 E, Fassnacht M, Jouinot A, Luscap W, Barreau O et al (2014) Integrated genomic characterization of adrenocortical carcinoma. Nat Genet 46:607\u2013612. https:\/\/doi.org\/10.1038\/ng.2953","journal-title":"Nat Genet"},{"key":"608_CR42","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1210\/jc.2014-3282","volume":"100","author":"CC Juhlin","year":"2015","unstructured":"Juhlin CC, Goh G, Healy JM, Fonseca AL, Scholl UI, Stenman A et al (2015) Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J Clin Endocrinol Metab 100:E493\u2013502. https:\/\/doi.org\/10.1210\/jc.2014-3282","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA et al (2016) Comprehensive Pan-genomic characterization of Adrenocortical Carcinoma. Cancer Cell 29:723\u2013736. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.002","journal-title":"Cancer Cell"},{"key":"608_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1126\/science.1249480","volume":"344","author":"Y Cao","year":"2014","unstructured":"Cao Y, He M, Gao Z, Peng Y, Li Y, Li L et al (2014) Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome. Science 344:913\u2013917. https:\/\/doi.org\/10.1126\/science.1249480","journal-title":"Science"},{"key":"608_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2956","volume":"46","author":"G Goh","year":"2014","unstructured":"Goh G, Scholl UI, Healy JM, Choi M, Prasad ML, Nelson-Williams C et al (2014) Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet 46:613\u2013617. https:\/\/doi.org\/10.1038\/ng.2956","journal-title":"Nat Genet"},{"key":"608_CR46","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1126\/science.1252328","volume":"344","author":"Y Sato","year":"2014","unstructured":"Sato Y, Maekawa S, Ishii R, Sanada M, Morikawa T, Shiraishi Y et al (2014) Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome. Science 344:917\u2013920. https:\/\/doi.org\/10.1126\/science.1252328","journal-title":"Science"},{"key":"608_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0042-120416","volume":"49","author":"GD Dalmazi","year":"2017","unstructured":"Dalmazi GD, Beuschlein F (2017) PRKACA mutations in adrenal adenomas: Genotype\/Phenotype correlations. Horm Metab Res 49:301\u2013306. https:\/\/doi.org\/10.1055\/s-0042-120416","journal-title":"Horm Metab Res"},{"key":"608_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/en.2018-00775","volume":"160","author":"K Bathon","year":"2019","unstructured":"Bathon K, Weigand I, Vanselow JT, Ronchi CL, Sbiera S, Schlosser A et al (2019) Alterations in protein kinase a substrate specificity as a potential cause of Cushing Syndrome. Endocrinology 160:447\u2013459. https:\/\/doi.org\/10.1210\/en.2018-00775","journal-title":"Endocrinology"},{"key":"608_CR49","doi-asserted-by":"publisher","first-page":"eabd4176","DOI":"10.1126\/sciadv.abd4176","volume":"7","author":"I Weigand","year":"2021","unstructured":"Weigand I, Ronchi CL, Vanselow JT, Bathon K, Lenz K, Herterich S et al (2021) PKA C\u03b1 subunit mutation triggers caspase-dependent RII\u03b2 subunit degradation via Ser114 phosphorylation. Sci Adv 7:eabd4176. https:\/\/doi.org\/10.1126\/sciadv.abd4176","journal-title":"Sci Adv"},{"key":"608_CR50","doi-asserted-by":"publisher","first-page":"e98296","DOI":"10.1172\/jci.insight.98296","volume":"3","author":"S Espiard","year":"2018","unstructured":"Espiard S, Knape MJ, Bathon K, Assi\u00e9 G, Rizk-Rabin M, Faillot S et al (2018) Activating PRKACB somatic mutation in cortisol-producing adenomas. JCI Insight 3:e98296. https:\/\/doi.org\/10.1172\/jci.insight.98296","journal-title":"JCI Insight"},{"key":"608_CR51","first-page":"5308","volume":"63","author":"J Bertherat","year":"2003","unstructured":"Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S et al (2003) Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 63:5308\u20135319","journal-title":"Cancer Res"},{"key":"608_CR52","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1210\/jc.2016-1586","volume":"101","author":"CL Ronchi","year":"2016","unstructured":"Ronchi CL, Di Dalmazi G, Faillot S, Sbiera S, Assi\u00e9 G, Weigand I et al (2016) Genetic Landscape of sporadic unilateral Adrenocortical Adenomas without PRKACA p.Leu206Arg mutation. J Clin Endocrinol Metab 101:3526\u20133538. https:\/\/doi.org\/10.1210\/jc.2016-1586","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR53","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1210\/jc.2010-1885","volume":"96","author":"S Bonnet","year":"2011","unstructured":"Bonnet S, Gaujoux S, Launay P, Baudry C, Chokri I, Ragazzon B et al (2011) Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J Clin Endocrinol Metab 96:E419\u2013426. https:\/\/doi.org\/10.1210\/jc.2010-1885","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/a-1107-2972","volume":"52","author":"F Hannah-Shmouni","year":"2020","unstructured":"Hannah-Shmouni F, Stratakis CA (2020) A gene-based classification of primary Adrenocortical Hyperplasias. Horm Metab Res 52:133\u2013141. https:\/\/doi.org\/10.1055\/a-1107-2972","journal-title":"Horm Metab Res"},{"key":"608_CR55","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","volume":"14","author":"R Lib\u00e9","year":"2008","unstructured":"Lib\u00e9 R, Fratticci A, Coste J, Tissier F, Horvath A, Ragazzon B et al (2008) Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res 14:4016\u20134024. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0106","journal-title":"Clin Cancer Res"},{"key":"608_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","volume":"77","author":"A Rothenbuhler","year":"2012","unstructured":"Rothenbuhler A, Horvath A, Lib\u00e9 R, Faucz FR, Fratticci A, Raffin Sanson ML et al (2012) Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours. Clin Endocrinol (Oxf) 77:195\u2013199. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04366.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"608_CR57","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00261-019-02048-6","volume":"45","author":"AC Morani","year":"2020","unstructured":"Morani AC, Jensen CT, Habra MA, Agrons MM, Menias CO, Wagner-Bartak NA et al (2020) Adrenocortical hyperplasia: a review of clinical presentation and imaging. Abdom Radiol (NY) 45:917\u2013927. https:\/\/doi.org\/10.1007\/s00261-019-02048-6","journal-title":"Abdom Radiol (NY)"},{"key":"608_CR58","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/JOE-14-0568","volume":"224","author":"MCBV Fragoso","year":"2015","unstructured":"Fragoso MCBV, Alencar GA, Lerario AM, Bourdeau I, Almeida MQ, Mendonca BB et al (2015) Genetics of primary macronodular adrenal hyperplasia. J Endocrinol 224:R31\u201343. https:\/\/doi.org\/10.1530\/JOE-14-0568","journal-title":"J Endocrinol"},{"key":"608_CR59","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","volume":"34","author":"I Bourdeau","year":"2020","unstructured":"Bourdeau I, Parisien-La Salle S, Lacroix A (2020) Adrenocortical hyperplasia: a multifaceted disease. Best Pract Res Clin Endocrinol Metab 34:101386. https:\/\/doi.org\/10.1016\/j.beem.2020.101386","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"608_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fendo.2020.00036","volume":"11","author":"BMDP Mariani","year":"2020","unstructured":"Mariani BMDP, Nishi MY, Wanichi IQ, Brondani VB, Lacombe AMF, Charchar H et al (2020) Allelic variants of ARMC5 in patients with adrenal incidentalomas and in patients with Cushing\u2019s Syndrome Associated with bilateral adrenal nodules. Front Endocrinol 11:36. https:\/\/doi.org\/10.3389\/fendo.2020.00036","journal-title":"Front Endocrinol"},{"key":"608_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M et al (2022) Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol 33:155\u2013196. https:\/\/doi.org\/10.1007\/s12022-022-09710-8","journal-title":"Endocr Pathol"},{"key":"608_CR62","doi-asserted-by":"publisher","unstructured":"Bouys L, Violon F, Louiset E, Sibony M, Lefebvre H, Bertherat J Bilateral Adrenocortical Nodular Disease and Cushing\u2019s syndrome. J Clin Endocrinol Metab 2024:dgae419. https:\/\/doi.org\/10.1210\/clinem\/dgae419","DOI":"10.1210\/clinem\/dgae419"},{"key":"608_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-11-0679","volume":"166","author":"B Gatta-Cherifi","year":"2012","unstructured":"Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V et al (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe D\u2019etude Des Tumeurs endocrines database. Eur J Endocrinol 166:269\u2013279. https:\/\/doi.org\/10.1530\/EJE-11-0679","journal-title":"Eur J Endocrinol"},{"key":"608_CR64","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1210\/jc.2004-2377","volume":"90","author":"L Matyakhina","year":"2005","unstructured":"Matyakhina L, Freedman RJ, Bourdeau I, Wei M-H, Stergiopoulos SG, Chidakel A et al (2005) Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab 90:3773\u20133779. https:\/\/doi.org\/10.1210\/jc.2004-2377","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR65","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","volume":"189","author":"B Shuch","year":"2013","unstructured":"Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R et al (2013) Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol 189:430\u2013435. https:\/\/doi.org\/10.1016\/j.juro.2012.07.139","journal-title":"J Urol"},{"key":"608_CR66","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1210\/jc.2002-021362","volume":"88","author":"MCBV Fragoso","year":"2003","unstructured":"Fragoso MCBV, Domenice S, Latronico AC, Martin RM, Pereira MAA, Zerbini MCN et al (2003) Cushing\u2019s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 88:2147\u20132151. https:\/\/doi.org\/10.1210\/jc.2002-021362","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR67","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assi\u00e9","year":"2013","unstructured":"Assi\u00e9 G, Lib\u00e9 R, Espiard S, Rizk-Rabin M, Guimier A, Luscap W et al (2013) ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome. N Engl J Med 369:2105\u20132114. https:\/\/doi.org\/10.1056\/NEJMoa1304603","journal-title":"N Engl J Med"},{"key":"608_CR68","doi-asserted-by":"publisher","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","volume":"99","author":"FR Faucz","year":"2014","unstructured":"Faucz FR, Zilbermint M, Lodish MB, Szarek E, Trivellin G, Sinaii N et al (2014) Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J Clin Endocrinol Metab 99:E1113\u20131119. https:\/\/doi.org\/10.1210\/jc.2013-4280","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR69","doi-asserted-by":"publisher","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","volume":"99","author":"GA Alencar","year":"2014","unstructured":"Alencar GA, Lerario AM, Nishi MY, Mariani BM, de Almeida P, Tremblay MQ (2014) ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J Clin Endocrinol Metab 99:E1501\u20131509. https:\/\/doi.org\/10.1210\/jc.2013-4237","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR70","doi-asserted-by":"publisher","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","volume":"99","author":"FR Faucz","year":"2014","unstructured":"Faucz FR, Zilbermint M, Lodish MB, Szarek E, Trivellin G, Sinaii N et al (2014) Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J Clin Endocrinol Metab 99:E1113\u2013E1119. https:\/\/doi.org\/10.1210\/jc.2013-4280","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR71","doi-asserted-by":"publisher","first-page":"E926","DOI":"10.1210\/jc.2014-4204","volume":"100","author":"S Espiard","year":"2015","unstructured":"Espiard S, Drougat L, Lib\u00e9 R, Assi\u00e9 G, Perlemoine K, Guignat L et al (2015) ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J Clin Endocrinol Metab 100:E926\u2013E935. https:\/\/doi.org\/10.1210\/jc.2014-4204","journal-title":"J Clin Endocrinol Metab"},{"key":"608_CR72","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/endrev\/bnac034","volume":"44","author":"J Bertherat","year":"2023","unstructured":"Bertherat J, Bourdeau I, Bouys L, Chasseloup F, Kamenick\u00fd P, Lacroix A (2023) Clinical, Pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal Hyperplasia. Endocr Rev 44:567\u2013628. https:\/\/doi.org\/10.1210\/endrev\/bnac034","journal-title":"Endocr Rev"},{"key":"608_CR73","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41574-022-00718-y","volume":"18","author":"IP Cavalcante","year":"2022","unstructured":"Cavalcante IP, Berthon A, Fragoso MC, Reincke M, Stratakis CA, Ragazzon B et al (2022) Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease. Nat Rev Endocrinol 18:699\u2013711. https:\/\/doi.org\/10.1038\/s41574-022-00718-y","journal-title":"Nat Rev Endocrinol"},{"key":"608_CR74","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","volume":"24","author":"A Vaczlavik","year":"2022","unstructured":"Vaczlavik A, Bouys L, Violon F, Giannone G, Jouinot A, Armignacco R et al (2022) KDM1A inactivation causes hereditary food-dependent Cushing syndrome. Genet Med 24:374\u2013383. https:\/\/doi.org\/10.1016\/j.gim.2021.09.018","journal-title":"Genet Med"},{"key":"608_CR75","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA et al (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941\u2013953. https:\/\/doi.org\/10.1016\/j.cell.2004.12.012","journal-title":"Cell"},{"key":"608_CR76","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc3884","volume":"15","author":"R Hamamoto","year":"2015","unstructured":"Hamamoto R, Saloura V, Nakamura Y (2015) Critical roles of non-histone protein lysine methylation in human tumorigenesis. Nat Rev Cancer 15:110\u2013124. https:\/\/doi.org\/10.1038\/nrc3884","journal-title":"Nat Rev Cancer"},{"key":"608_CR77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/EJE-10-0058","volume":"163","author":"JWB de Groot","year":"2010","unstructured":"de Groot JWB, Links TP, Themmen APN, Looijenga LH, de Krijger RR, van Koetsveld PM et al (2010) Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing\u2019s syndrome. Eur J Endocrinol 163:293\u2013299. https:\/\/doi.org\/10.1530\/EJE-10-0058","journal-title":"Eur J Endocrinol"},{"key":"608_CR78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10689-013-9642-y","volume":"12","author":"J Zhu","year":"2013","unstructured":"Zhu J, Cui L, Wang W, Hang X-Y, Xu A-X, Yang S-X et al (2013) Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia. Fam Cancer 12:657\u2013667. https:\/\/doi.org\/10.1007\/s10689-013-9642-y","journal-title":"Fam Cancer"},{"key":"608_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11102-006-0266-1","volume":"9","author":"L Cazabat","year":"2006","unstructured":"Cazabat L, Ragazzon B, Groussin L, Bertherat J (2006) PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary 9:211\u2013219. https:\/\/doi.org\/10.1007\/s11102-006-0266-1","journal-title":"Pituitary"},{"key":"608_CR80","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1086\/344579","volume":"71","author":"L Groussin","year":"2002","unstructured":"Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B et al (2002) Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 71:1433\u20131442. https:\/\/doi.org\/10.1086\/344579","journal-title":"Am J Hum Genet"},{"key":"608_CR81","doi-asserted-by":"publisher","unstructured":"Bouys L, Bertherat J, MANAGEMENT OF ENDOCRINE, DISEASE (2021) Carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene. Eur J Endocrinol 184:R99\u2013109. https:\/\/doi.org\/10.1530\/EJE-20-1120","DOI":"10.1530\/EJE-20-1120"},{"key":"608_CR82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS et al (2000) Mutations of the gene encoding the protein kinase a type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89\u201392. https:\/\/doi.org\/10.1038\/79238","journal-title":"Nat Genet"},{"key":"608_CR83","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/humu.21178","volume":"31","author":"A Horvath","year":"2010","unstructured":"Horvath A, Bertherat J, Groussin L, Guillaud-Bataille M, Tsang K, Cazabat L et al (2010) Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat 31:369\u2013379. https:\/\/doi.org\/10.1002\/humu.21178","journal-title":"Hum Mutat"},{"key":"608_CR84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.humpath.2014.09.005","volume":"46","author":"JA Carney","year":"2015","unstructured":"Carney JA, Lyssikatos C, Lodish MB, Stratakis CA (2015) Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes. Hum Pathol 46:40\u201349. https:\/\/doi.org\/10.1016\/j.humpath.2014.09.005","journal-title":"Hum Pathol"},{"key":"608_CR85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ando.2024.01.005","volume":"85","author":"L Martinerie","year":"2024","unstructured":"Martinerie L, Bouligand J, North M-O, Bertherat J, Assi\u00e9 G, Espiard S (2024) Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) for the diagnosis of Cushing\u2019s syndrome: Genetics of Cushing\u2019s syndrome. Ann Endocrinol (Paris) 85:284\u2013293. https:\/\/doi.org\/10.1016\/j.ando.2024.01.005","journal-title":"Ann Endocrinol (Paris)"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00608-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T10:13:11Z","timestamp":1730110391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00608-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00608-0","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no Competing Interests for this review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}